Verdence Capital Advisors’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.94M | Buy |
16,588
+4,080
| +33% | +$848K | 0.21% | 111 |
|
|
2026
Q1 | $2.64M | Sell |
12,508
-133
| -1% | -$28.6K | 0.15% | 137 |
|
|
2025
Q4 | $2.6M | Sell |
12,641
-2,329
| -16% | -$438K | 0.15% | 143 |
|
|
2025
Q3 | $2.45M | Sell |
14,970
-110
| -0.7% | -$17K | 0.14% | 153 |
|
|
2025
Q2 | $2.53M | Sell |
15,080
-4,363
| -22% | -$648K | 0.17% | 126 |
|
|
2025
Q1 | $2.68M | Sell |
19,443
-3,476
| -15% | -$443K | 0.2% | 116 |
|
|
2024
Q4 | $2.71M | Sell |
22,919
-5,481
| -19% | -$640K | 0.22% | 119 |
|
|
2024
Q3 | $3.14M | Sell |
28,400
-3,228
| -10% | -$338K | 0.25% | 106 |
|
|
2024
Q2 | $3.11M | Buy |
31,628
+873
| +3% | +$89K | 0.28% | 91 |
|
|
2024
Q1 | $3.44M | Buy |
30,755
+692
| +2% | +$74.7K | 0.31% | 81 |
|
|
2023
Q4 | $3.03M | Sell |
30,063
-2,881
| -9% | -$286K | 0.29% | 92 |
|
|
2023
Q3 | $2.86M | Buy |
32,944
+2,246
| +7% | +$203K | 0.31% | 86 |
|
|
2023
Q2 | $2.9M | Buy |
30,698
+548
| +2% | +$46.3K | 0.34% | 80 |
|
|
2023
Q1 | $2.28M | Buy |
30,150
+302
| +1% | +$22.8K | 0.28% | 95 |
|
|
2022
Q4 | $2.29M | Sell |
29,848
-2,060
| -6% | -$157K | 0.28% | 89 |
|
|
2022
Q3 | $2.13M | Sell |
31,908
-4,914
| -13% | -$311K | 0.29% | 95 |
|
|
2022
Q2 | $1.93M | Sell |
36,822
-1,604
| -4% | -$91.2K | 0.25% | 106 |
|
|
2022
Q1 | $2.18M | Buy |
38,426
+10,160
| +36% | +$544K | 0.25% | 104 |
|
|
2021
Q4 | $1.46M | Buy |
28,266
+3,056
| +12% | +$150K | 0.17% | 133 |
|
|
2021
Q3 | $1.25M | Buy |
25,210
+38
| +0.2% | +$2.06K | 0.16% | 141 |
|
|
2021
Q2 | $1.44M | Buy |
25,172
+1,708
| +7% | +$99.8K | 0.2% | 117 |
|
|
2021
Q1 | $1.43M | Buy |
23,464
+3,670
| +19% | +$203K | 0.24% | 109 |
|
|
2020
Q4 | $1.06M | Buy |
19,794
+668
| +3% | +$34.7K | 0.2% | 123 |
|
|
2020
Q3 | $898K | Buy |
19,126
+3,603
| +23% | +$185K | 0.21% | 123 |
|
|
2020
Q2 | $810K | Sell |
15,523
-10,404
| -40% | -$536K | 0.2% | 128 |
|
|
2020
Q1 | $1.24M | Sell |
25,927
-2,880
| -10% | -$150K | 0.37% | 77 |
|
|
2019
Q4 | $1.46M | Sell |
28,807
-45
| -0.2% | -$2.32K | 0.36% | 75 |
|
|
2019
Q3 | $1.36M | Buy |
28,852
+5,973
| +26% | +$273K | 0.38% | 74 |
|
|
2019
Q2 | $1.08M | Buy |
22,879
+9,013
| +65% | +$416K | 0.31% | 94 |
|
|
2019
Q1 | $668K | Buy |
+13,866
| New | +$695K | 0.18% | 136 |
|
|
2018
Q2 | – | Sell |
-3,382
| Closed | -$212K | – | 296 |
|
|
2018
Q1 | $212K | Buy |
+3,382
| New | +$232K | 0.05% | 266 |
|
Other funds holding CAH
Verdence Capital Advisors's CAH Position: Q2 2026 in Review
Verdence Capital Advisors increased its Cardinal Health (CAH) stake by 33% in Q2 2026, buying an estimated $848K and bringing the position to 16,588 shares worth $3.94M. The position accounts for 0.21% of the portfolio, ranked #111.
Verdence Capital Advisors first reported a position in CAH in Q1 2018 and has held it in 31 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Verdence Capital Advisors held 16,588 shares of Cardinal Health worth $3.94M as of Q2 2026.
- Verdence Capital Advisors bought 4,080 Cardinal Health shares in Q2 2026, an estimated $848K.
- Cardinal Health made up 0.21% of Verdence Capital Advisors's portfolio in Q2 2026, its #111 holding.
- Verdence Capital Advisors first reported a position in Cardinal Health in Q1 2018 and has held it in 31 quarters since.
- 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.